Sang-Gyu Park

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer diagnosisAutoimmunityPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2025
Preclinical Antitumor Efficacy of a Novel Anti-c-Kit Antibody-Drug Conjugate, NN3201, in c-Kit-Positive Tumors.

Chansik Kim, Jinwoo Park, Jin-Ock Kim

|Sep 05, 2025
Preclinical Antitumor Efficacy of a Novel Anti-c-Kit Antibody-Drug Conjugate, NN3201, in c-Kit-Positive Tumors.

Chansik Kim, Jinwoo Park, Jin-Ock Kim

|Feb 10, 2024
CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata.

Mei Zheng, Min-Ho Kim, Sang-Gyu Park

|Oct 27, 2022
A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models.

Yun Hee Sim, Yun Jung Um, Jeong-Yang Park

|Feb 26, 2022
Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer.

Kwang-Hyeok Kim, Jin-Ock Kim, Jeong-Yang Park

|Aug 28, 2021
A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice.

Songyi Seo, Koung Li Kim, Yeongju Yeo

Pageof 2

Frequent Collaborators

2 joint publications

Jina Lee

2 joint publications

Sohyeon Park

2 joint publications

TaeMin Wi

2 joint publications

Yeonjy Lee